• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/13/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Date of event has been estimated based on date of article publication.Date of implant has been estimated based on date of first patient enrollment.Alert date has been estimated based on date the article was read.The scafold remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Literature: angiographic and midterm outcomes of bioresorbable vascular scaffold for coronary bifurcation lesions.Author- pieter smits, american journal of cardiology 122.12: 2035-2042.Elsevier inc.(dec 15, 2018).The additional adverse patient effects and patient deaths referenced in the article are being filed under separate medwatch report #s.
 
Event Description
It was reported through a data review of 107 patients between july 2009 and december 2015 identifying absorb bioresorbable vascular scaffolds (bvs) that may be related to malapposed scaffold struts.Article titled "angiographic and midterm outcomes of bioresorbable vascular scaffold for coronary bifurcation lesions".
 
Manufacturer Narrative
Internal file number: (b)(4).The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the part and lot number were not provided.Based on the information reviewed, a conclusive cause for the reported difficulty to deploy could not be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8358101
MDR Text Key136761893
Report Number2024168-2019-01275
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Remedial Action Other
Type of Report Initial,Followup
Report Date 03/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/21/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received03/05/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age59 YR
-
-